The interfacial behavior of the newly designed Fluorocarbon Hydrocarbon Cationic Lipid (FHCL or CH(3)(CH(2))(17)N(+)(C(2)H(5))(2)(CH(2))(3)(CF(2))(7)CF(3)I(-)) and its mixtures with a phospholipid (DPPC, Dipalmitoylphosphatidylcholine) at different mole fractions were investigated. This new molecule was synthesized to mimic the selected properties of lung surfactant, which is a natural lipid-protein mixture which is known to play important roles in the process of respiration, by considering the structure/function relation of lung surfactant protein (SP-C). Each segment in the molecular structure was selected to affect the molecular level interaction at the interface whereas the keeping the overall structure as simple as possible. The surface pressure area isotherms obtained for the mixtures of DPPC/FHCL indicated that there was repulsive interaction between DPPC and FHCL molecules. Due to the molecular level interaction, specifically at mole fraction 0.3, the isotherm obtained from that mixture resembled the isotherm obtained from the DPPC monolayer in the presence of SP-C. High elasticity of the interface was one of the important parameters for the respiration process, therefore, shear and dilatational elasticities of two-component systems were determined and they were found to be similar to the case where SP-C protein is present. Fluorescence microscopy images were taken in order to investigate the monolayer in details. The FHCL was able to fluidize the DPPC monolayer even at high surface pressures effectively. In addition, the cyclic compression-expansion isotherms were obtained to understand the spreading and re-spreading ability of the pure FHCL and the mixed DPPC/FHCL monolayers. At a specific mole fraction, X(FHCL)=0.3, the mixture exhibited good hysteresis in area, compressibility, recruitment index and re-spreading ability at the interface. All these results point out that FHCL can fulfill the selected features of the lung surfactant that are attributed to the presence of SP-C protein when mixed with DPPC, even if the molecular structure of the FHCL is quite simple.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcis.2011.04.018DOI Listing

Publication Analysis

Top Keywords

lung surfactant
16
surfactant protein
8
molecular structure
8
molecular level
8
level interaction
8
mole fraction
8
dppc monolayer
8
presence sp-c
8
sp-c protein
8
re-spreading ability
8

Similar Publications

Autoimmune pulmonary alveolar proteinosis (aPAP), which accounts for >90% of all cases of PAP, is a rare lung disease mediated by granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies that block GM-CSF signalling, leading to reduced surfactant clearance causing abnormal accumulation of alveolar surfactant and impaired gas exchange [1-3]. The current standard of care for aPAP is whole-lung lavage (WLL), which is invasive, resource intensive, carries procedural risk, does not address the underlying cause of disease and often must be repeated regularly [4]. Hence, there is a therapeutical need to address the underlying pathophysiology of the disease.

View Article and Find Full Text PDF

The role of surfactant proteins A and D (SP-A and SP-D) in lung clearance and translocation to secondary organs of inhaled nanoparticles was investigated by exposing SP-A and SP-D knockout (AKO and DKO) and wild type (WT) mice nose-only for 3 hours to an aerosol of 20 nm gold nanoparticles (AuNPs). Animals were euthanised at 0-, 1-, 7- and 28-days post-exposure. Analysis by inductively coupled plasma mass spectrometry (ICP-MS) of the liver and kidneys showed that extrapulmonary translocation was below the limits of detection.

View Article and Find Full Text PDF

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques.

Pharmaceutics

January 2025

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.

Nanosuspensions (NS), with their submicron particle sizes and unique physicochemical properties, provide a versatile solution for enhancing the administration of medications that are not highly soluble in water or lipids. This review highlights recent advancements, future prospects, and challenges in NS-based drug delivery, particularly for oral, ocular, transdermal, pulmonary, and parenteral routes. The conversion of oral NS into powders, pellets, granules, tablets, and capsules, and their incorporation into film dosage forms to address stability concerns is thoroughly reviewed.

View Article and Find Full Text PDF

Pulmonary alveolar proteinosis (PAP) is a rare pulmonary pathology characterized by the accumulation of surfactant within type II alveolar epithelial cells. Whole lung lavage is the standard treatment for pulmonary alveolar proteinosis involving a large volume of fluid is infused into one lung and subsequently retrieved while the other lung is remains ventilated. Fast-tracking a patient undergoing whole lung lavage requires vigilant monitoring of arterial blood gases, fluid status, and respiratory mechanics.

View Article and Find Full Text PDF

The innate immune system plays a critical role in the rapid recognition and elimination of pathogens through pattern recognition receptors (PRRs). Among these PRRs are the C-type lectins (CTLs) langerin, mannan-binding lectin (MBL), and surfactant protein D (SP-D), which recognize carbohydrate patterns on pathogens. Each represents proteins from different compartments of the body and employs separate effector mechanisms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!